NOUMENON
The computed 12-month bankruptcy probability of NOUMENON is 0.1% (very low). The 2025 annual accounts show equity of €286k and a net result of €88k. Equity is growing by ~42.4% per year across the filed fiscal years. Its solvency ranks better than 92% of 2204 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €286k |
| Net result | €88k |
| Better than sector | 92% |
| Active | 4 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 94.6% | 58.0% | |
| Net result | €88k | €60k | |
| Equity | €286k | €74k | |
| Gross operating margin | €130k | €96k | |
| Total assets | €302k | €186k |
| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €130k |
| Net profit | €88k |
| Cash flow | €96k |
| Staff costs | - |
| Income taxes | €34k |
| Dividends | - |
| Total assets | €302k |
| Equity | €286k |
| Debt | €16k |
| of which ≤ 1y | €16k |
| of which > 1y | - |
| Working capital | €221k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 14.64 |
| Quick ratio | 14.64 |
| Working capital ratio | 73.1% |
| Solvency | 94.6% |
| Debt / equity | 0.06 |
| Long-term debt ratio | - |
| Interest coverage | 756.68 |
| Gross margin | - |
| Net margin | - |
| ROA | 29.0% |
| ROE | 30.6% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €302k |
| Fixed assets | 21/28 | €65k |
| Tangible fixed assets | 22/27 | €17k |
| Financial fixed assets | 28 | €48k |
| Current assets | 29/58 | €237k |
| Amounts receivable within one year | 40/41 | €78k |
| Cash & bank | 54/58 | €155k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €302k |
| Equity | 10/15 | €286k |
| Contributions / capital | 10/11 | €10k |
| Reserves | 13 | €276k |
| Accumulated profits (losses) | 14 | €9 |
| Amounts payable | 17/49 | €16k |
| Amounts payable within one year | 42/48 | €16k |
| Trade debts payable within one year | 44 | €4k |
| Income statement | ||
| Gross operating margin | 9900 | €130k |
| Operating result | 9901 | €122k |
| Financial income | 75 | €261 |
| Financial charges | 65 | €172 |
| Result before taxes | 9903 | €122k |
| Income taxes | 67/77 | €34k |
| Net result for the period | 9904 | €88k |
| Result to be appropriated | 9905 | €88k |
| NACE primary | Human health(86931) |
| Legal form | Private limited company(610) |
| Incorporation | 27-01-2022 |
| Status | Active |
| Postal code | 1740 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23086B0224/00H000 | Flanders | 3,851 m² | 1 · 397 m² | 0.1 m |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
22-01-2026 Registered office moved from Dilbeek to Temse
- Bigardisweg 8, 1702 Dilbeek → Assesteenweg 71, 1740 Temse
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Temse",
"region": "Vlaams Gewest",
"street": "Assesteenweg",
"country": "BE",
"postcode": "1740",
"box_number": null,
"street_number": "71"
},
"old_address": {
"city": "Dilbeek",
"region": "Vlaams Gewest",
"street": "Bigardisweg",
"country": "BE",
"postcode": "1702",
"box_number": "201",
"street_number": "8"
},
"effective_date": "2025-07-01",
"evidence_quote": "De zetel van de vennootschap is sedert 1/07/2025 verplaatst van 1702 Dilbeek, Bigardisweg 8 Bus 201 naar 1740 Temat, Assesteenweg 71"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0780.942.149",
"name_full": "NOUMENON",
"legal_form": "BV"
}
}31-01-2022 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "1702 Groot-Bijgaarden, Bigardisweg 8/201",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1987-08-18",
"name": "Claes Stijn",
"niss": null,
"address": "Lennik, Schapenstraat 218"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 10000,
"holder_person_name": "Claes Stijn",
"is_subscriber_only": false,
"n_shares_subscribed": 200,
"amount_subscribed_eur": 10000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 10000,
"subject_company": {
"kbo": "0780.942.149",
"name_full": "NOUMENON",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2022-01-26",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | NOUMENON |